Articles

 Zachary Klaassen speaks with Steven Finkelstein about the FDA approval of Pluvicto™ (177Lu-PSMA-617) in the pre-chemotherapy setting for metastatic castration-resistant prostate cancer. Dr. [...]

Article by Marty Stempniak | Radiology Business | See article online here   A private equity-backed urology group continues its expansion into interventional radiology with the opening of a [...]

November 2, 2020 — If anything is certain heading into Tuesday’s general election, it is that 2020 has been a year like no other. Widespread uncertainty over so many issues – ranging from the [...]

August 5, 2020 — U.S. Urology Partners, a urology platform backed by New MainStream (NMS) Capital, has resumed talks with acquisition targets as business returns to normal levels, said CEO Mark [...]

Sponsor funds are set to flow into the urology space, which is seen as the next physician specialty du jour, industry sources said. With a stable reimbursement environment and steady demand for [...]

August 5, 2019 — U.S. Urology Partners, the new urology platform formed by New MainStream (NMS) Capital and the physicians of Central Ohio Urology Group (COUG), is actively seeking acquisitions [...]